Inflammatory Marker Articles & Analysis: Older
9 news found
Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced biomarker data from the KALM-1 and KALM-2 clinical trials evaluating KORSUVA™ (difelikefalin) injection for the treatment of chronic kidney disease-associated pruritus in patients undergoing ...
The funds will be used to develop a rapid, quantitative, multiplexed test for C-reactive proteins (CRP), inducible-proteins 10 (IP-10 or CXCL-10), and other inflammatory markers, which are known as cytokines and chemokines. The LightDeck® Analyzer’s inflammation panel is expected to help healthcare providers determine the status of a patient’s ...
Cytokines, including interleukins, interferons, tumor necrosis factors, and chemokines, can play key pro- and anti-inflammatory roles in vivo through a variety of biochemical pathways and interactions. Compared with other types of testing methods for infections and inflammatory diseases, the detection of cytokines has the advantages of non-invasiveness and low ...
Traggis started working with LightDeck Diagnostics founder Chris Myatt at a previous endeavor, Precision Photonics, a Boulder-based manufacturer of laser optics, in the early 2000s. Originally named MBio Diagnostics, LightDeck began as a “skunkworks effort” inside Precision. “I ended up taking over the reins there at Precision Photonics around the time Chris started focusing ...
Pre-clinical results have shown that the bacteria exert an anti-inflammatory effect on certain markers associated with itch. Company studies have also shown the potential antimicrobial mechanism of action that contribute to the reduction of pathogenic bacteria infecting the established skin lesions," said Board of Director, Dr. ...
Pre-clinical results have shown that the bacteria exert an anti-inflammatory effect on certain markers associated with itch. Company studies have also shown the potential antimicrobial mechanism of action that contribute to the reduction of pathogenic bacteria infecting the established skin lesions," said Board of Director, Dr. ...
Findings from a new study published today in Pediatric Research show that feeding activated Bifidobacterium infantis (B. infantis) EVC001 to breastfed infants reduced markers of chronic intestinal inflammation by up to 98 percent during the first two months of life, which is a critical period of immune system development. ...
They also say that, since the higher risk of CVD in women who have had GDM is not dependent on T2D, it could be related to one or more other risk factors, including increased inflammatory markers such as C-reactive protein, higher levels of blood fats, low levels of HDL (good) cholesterol and higher levels of LDL (bad) cholesterol. ...
Delegates of five elites from Getein Biotech exhibited their latest Point of Care Testing (POCT) analyzer and Cardiac, Inflammatory, Kidney disease Markers and new systems CLIA6800, Biochemistry System CM800. ...